Company intelligence / Profile preview

Bioscientia

Ingelheim am Rhein, Rhineland-Palatinate, Germany

Ownership: Private
Employees: ~2500
Development stage: Other

Overview

Bioscientia is a leading provider of clinical laboratory testing services, encompassing human genetics, infectious diseases, oncology, rare diseases, and veterinary medicine. As a Contract Research Organization (CRO), it supports clinical trials from phases I to IV, offering expertise in molecular biology, toxicology, infectious diseases, and immunology. The company operates commercially with multiple accreditations, including CAP and ISO 15189.

Industry: Molecular Diagnostics

Partnerships

Sonic HealthcarePacBioBoehringer Ingelheim (historical)College of American Pathologists (CAP)

Beyond the preview

Go deeper on Bioscientia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioscientia.

Explore the full profile